Infectious complications in cancer patients treated with anti-EGFR monoclonal antibodies cetuximab and panitumumab: A systematic review and meta-analysis

The use of anti-EGFR mAbs is associated with a significantly higher risk of high-grade infection and febrile neutropenia.